Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04185285

Percutaneous Coronary Intervention Registry FRIBOURG

The registry aims to follow clinically all consecutive patients treated by percutaneous coronary interventions at hospital & university Fribourg.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Coronary Artery Disease Arterial Occlusive Diseases Arteriosclerosis Cardiovascular Diseases Coronary Disease Heart Diseases Myocardial Ischemia Percutaneous Coronary Intervention Vascular Diseases

Age range

17 year–120 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Cardiology, university Fribourg Medical Center

Fribourg, 1708, Switzerland

Location status: Recruiting

Location contact

Cook Y. Stephane, MD

CONTACT

[email protected]

+41263063800

Diego Arroyo, MD

PRINCIPAL_INVESTIGATOR

Mario Togni, MD

PRINCIPAL_INVESTIGATOR

Masset Lea, BSc

CONTACT

[email protected]

+41263063800

Serban Puricel, MD

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All consecutive patients treated by percutaneous coronary intervention at our institution
  • Able to give informed consent and willing to participate

Exclusion criteria

  • Unwillingness to participate
  • Enable to provide inform consent

Treatment and study plan

Percutaneous coronary intervention, stents

Device

Primary outcomes

  1. Patient-oriented composite endpoints (POCE)

    Time frame: 2 years

    Academic Research Consortium definition

  2. Major Bleeding

    Time frame: 2 years

    Bleeding Academic Research Consortium definition

  3. Patient-oriented composite endpoints (POCE)

    Time frame: 5 years

    Academic Research Consortium definition

  4. Major Bleeding

    Time frame: 5 years

    Bleeding Academic Research Consortium definition

  5. Patient-oriented composite endpoints (POCE)

    Time frame: 10 years

    Academic Research Consortium definition

  6. Major Bleeding

    Time frame: 10 years

    Bleeding Academic Research Consortium definition

Secondary outcomes

  1. all-cause death

    Time frame: 2 years

    Academic Research Consortium definition

  2. any revascularization

    Time frame: 2 years

    Academic Research Consortium definition

  3. any myocardial infarction

    Time frame: 2 years

    Academic Research Consortium definition

Sponsors and collaborators

Lead sponsor

University of Freiburg

Other

Registry information

Acronym: Cardio-FR

Important dates

Study start
2015
Primary completion
2017
Study completion
2027
First posted
Dec 4, 2019
Registry last updated
Oct 22, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.